Physician
Om Sakthi P.A.
Om Sakthi P.A. was paid $1.20M by Medicaid between Jan 2018 and Dec 2024, across 98 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 39% of everything it billed.
33Billing provider infoOM SAKTHI P.A.
SEALY, TX 77474
SEALY, TX 77474
33aNPI1578565206assigned 08/12/2005
33bProvider typeInternal Medicine Physician
28Total paid$1.20M
24GClaims95,046
24DCodes billed98
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Internal Medicine Physician providers in Texas
Rank by total paid#35 of 1,028
Median peer was paid$10K
This provider vs. median115×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 3,766 | $19K | |
| 2019 | 3,812 | $16K | |
| 2020 | 8,441 | $63K | |
| 2021 | 24,153 | $335K | |
| 2022 | 22,965 | $295K | |
| 2023 | 21,501 | $307K | |
| 2024incomplete | 10,408 | $165K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 39% | 13,866 | 11,668 | $465K |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 23% | 7,408 | 5,969 | $279K |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | 6.0% | 767 | 726 | $71K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 4.8% | 668 | 642 | $58K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 4.4% | 4,006 | 1,874 | $52K |
| 99203 | Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 3.3% | 660 | 639 | $39K |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | 2.8% | 3,071 | 1,444 | $33K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 2.1% | 1,847 | 1,744 | $25K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 1.6% | 611 | 529 | $19K |
| 99204 | Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | 1.5% | 225 | 218 | $18K |
| M0243 | Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring | 1.3% | 65 | 55 | $16K |
| 99000 | 1.3% | 1,488 | 1,367 | $16K |
86 more codes
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 1.3% | 325 | $15K |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | <1% | 132 | $11K |
| 80053 | Comprehensive metabolic panel | <1% | 2,153 | $8K |
| 80061 | Lipid panel | <1% | 1,659 | $7K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 2,159 | $6K |
| G2023 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | <1% | 582 | $6K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 601 | $5K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 310 | $5K |
| 87428 | <1% | 119 | $4K | |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 604 | $3K |
| 97169 | <1% | 222 | $3K | |
| 93000 | <1% | 468 | $3K | |
| 87807 | <1% | 256 | $3K | |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | <1% | 34 | $3K |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 1,108 | $3K |
| 99337 | <1% | 44 | $3K | |
| 92551 | <1% | 590 | $2K | |
| 90461 | <1% | 366 | $2K | |
| 84703 | <1% | 347 | $2K | |
| 81003 | <1% | 1,476 | $2K | |
| 0071A | <1% | 41 | $2K | |
| 99215 | Doctor's office visit, returning patient (complex) | <1% | 40 | $2K |
| 90674 | <1% | 258 | $1K | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 66 | $985.27 |
| 0072A | <1% | 22 | $894.00 | |
| 99310 | Prolong nursin fac eval 15m | <1% | 26 | $746.94 |
| 71046 | Radiologic examination, chest; 2 views | <1% | 58 | $738.49 |
| 87811 | Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) | <1% | 17 | $559.63 |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 74 | $307.46 |
| 90734 | <1% | 220 | $246.51 | |
| 99309 | Subsequent nursing facility care, per day, low to moderate complexity | <1% | 76 | $241.26 |
| 0011A | <1% | 27 | $240.00 | |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | <1% | 17 | $165.66 |
| 0013A | <1% | 15 | $160.00 | |
| 99072 | <1% | 822 | $150.00 | |
| 99350 | Prolong home eval add 15m | <1% | 15 | $138.17 |
| 0031A | <1% | 38 | $135.87 | |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 59 | $131.70 |
| G2211 | Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) | <1% | 144 | $85.05 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 129 | $54.16 |
| 90651 | <1% | 89 | $50.01 | |
| A4208 | Syringe with needle, sterile 3 cc, each | <1% | 418 | $42.25 |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 53 | $15.39 |
| 96127 | <1% | 147 | $8.88 | |
| J7620 | Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme | <1% | 66 | $8.30 |
| 94760 | <1% | 66 | $4.22 | |
| 36415 | Collection of venous blood by venipuncture | <1% | 3,136 | $3.60 |
| A7003 | Administration set, with small volume nonfiltered pneumatic nebulizer, disposable | <1% | 58 | $2.18 |
| 91307 | <1% | 67 | $0.05 | |
| 90662 | <1% | 12 | $0.03 | |
| Q0243 | Injection, casirivimab and imdevimab, 2400 mg | <1% | 64 | $0.03 |
| 91303 | <1% | 37 | $0.02 | |
| G9744 | Patient not eligible due to active diagnosis of hypertension | 0% | 1,141 | $0.00 |
| G8753 | Most recent systolic blood pressure >= 140 mmhg | 0% | 454 | $0.00 |
| 99173 | 0% | 2,096 | $0.00 | |
| G8752 | Most recent systolic blood pressure < 140 mmhg | 0% | 395 | $0.00 |
| 1159F | 0% | 5,124 | $0.00 | |
| 90670 | 0% | 15 | $0.00 | |
| G8427 | Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications | 0% | 9,827 | $0.00 |
| Q2037 | Influenza virus vaccine, split virus, when administered to individuals 3 years of age and older, for intramuscular use (fluvirin) | 0% | 79 | $0.00 |
| G8417 | Bmi is documented above normal parameters and a follow-up plan is documented | 0% | 1,519 | $0.00 |
| 90633 | 0% | 31 | $0.00 | |
| G8482 | Influenza immunization administered or previously received | 0% | 153 | $0.00 |
| 90715 | 0% | 92 | $0.00 | |
| 90707 | 0% | 15 | $0.00 | |
| G0444 | Annual depression screening, 5 to 15 minutes | 0% | 30 | $0.00 |
| 91300 | 0% | 15 | $0.00 | |
| G8783 | Normal blood pressure reading documented, follow-up not required | 0% | 60 | $0.00 |
| 90710 | 0% | 27 | $0.00 | |
| G8420 | Bmi is documented within normal parameters and no follow-up plan is required | 0% | 534 | $0.00 |
| 3008F | 0% | 4,149 | $0.00 | |
| G8754 | Most recent diastolic blood pressure < 90 mmhg | 0% | 990 | $0.00 |
| G9903 | Patient screened for tobacco use and identified as a tobacco non-user | 0% | 2,998 | $0.00 |
| G8419 | Bmi documented outside normal parameters, no follow-up plan documented, no reason given | 0% | 123 | $0.00 |
| 2010F | 0% | 5,165 | $0.00 | |
| 1036F | 0% | 4,671 | $0.00 | |
| A9150 | Non-prescription drugs | 0% | 18 | $0.00 |
| G9902 | Patient screened for tobacco use and identified as a tobacco user | 0% | 322 | $0.00 |
| G0008 | Administration of influenza virus vaccine | 0% | 169 | $0.00 |
| 90650 | 0% | 12 | $0.00 | |
| G0447 | Face-to-face behavioral counseling for obesity, 15 minutes | 0% | 23 | $0.00 |
| 91301 | 0% | 72 | $0.00 | |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 0% | 33 | $0.00 |
| 90696 | 0% | 30 | $0.00 | |
| G8755 | Most recent diastolic blood pressure >= 90 mmhg | 0% | 36 | $0.00 |
| G0506 | Comprehensive assessment of and care planning for patients requiring chronic care management services (list separately in addition to primary monthly care management service) | 0% | 14 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialKRISHNASWAMY, KANNAPPAN (PRESIDENT)
| Provider | Location | Paid |
|---|---|---|
| Sealy Urgent Care Center P.A. | Sealy, TX | $109K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.